Cargando…
Targeting transforming growth factor β to enhance cancer immunotherapy
Autores principales: | Hahn, T., Akporiaye, E.T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891186/ https://www.ncbi.nlm.nih.gov/pubmed/17576455 |
Ejemplares similares
-
Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies
por: Jiang, W.G.
Publicado: (2007) -
Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
por: Bonfil, R.D., et al.
Publicado: (2008) -
Protein tyrosine phosphatases: new markers and targets in oncology?
por: Hardy, S., et al.
Publicado: (2008) -
Reverting Immune Suppression to Enhance Cancer Immunotherapy
por: Guerrouahen, Bella S., et al.
Publicado: (2020) -
The role of dna hypermethylation and demethylation in cancer and cancer therapy
por: Szyf, M.
Publicado: (2008)